Share
Optimum Perspectives
Interviews with industry leaders of the healthcare sector.
Latest episode
29. Ariceum Therapeutics: Pioneering research into next-generation radiopharmaceutical therapy targeting hard-to-treat cancers
09:58||Ep. 29The latest epiosde of Optimum Perspectives Podcast features Germo Gericke, CMO of Ariceum Therapeutics. Listen as he discusses how the company aims to improve outcomes for patients with lung cancer with radioligand therapy this Lung Cancer Awareness Month.
More episodes
View all episodes
28. Kling Biotherapeutics: Using B cell tech to discover new targets and antibodies in cancer
09:17||Ep. 28Great new insights in the Optimum Perspectives' latest podcast edition featuring Stefano Gullà, Chief Scientific Officer at Kling Biotherapeutics, about the growing role of B cell technology in cancer therapy.27. DISCO Pharmaceuticals looks to unlock new drugs with “surfaceome” technology
15:51||Ep. 27In this podcast to mark Lung Cancer Awareness Month, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of Disco Pharmaceuticals, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology.26. SpliceBio: Celebrating progress in ophthalmology research on World Sight Day
11:42||Ep. 26Optimum’s Richard Staines talks to Feride Sahin, Senior Director of Clinical Development at Splice Bio about the importance of World Sight Day, which takes place this week.25. Heidelberg Pharma – turning deadly mushroom toxin into cancer medicine
14:24||Ep. 25It’s time to talk about mushrooms! Or rather the deadly toxin amanitin found in the death cap mushroom, which Heidelberg Pharma is using as a cancer drug with the help of a tumour-targeting antibody, find out more in this episode featuring Heidelberg Pharma's CEO, Andreas Pahl.24. Resolution Therapeutics: pioneering macrophage therapies for liver diseases
27:55||Ep. 24Check out Optimum’s latest podcast episode profiling our client Resolution Therapeutics. Lara Campana, VP of Research Operations outlines the company’s technology based around pro-regenerative macrophages and its potential to treat liver disease.23. Q&A with Dr Ruth McKernan CBE: Neuroscientist, businesswoman and innovation leader
21:42||Ep. 23Dr Ruth McKernan CBE is the richly deserved winner of the 2024 Mediscience Award for ‘Most Significant Contribution to the Mediscience Sector’. In this episode Optimum’s Eva Haas discusses the highlights of Ruth’s incredible career, the skills needed for success as a company founder and the heartening advancements in treating neurodegenerative diseases such as Alzheimer's in recent years.